Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

43.95
Delayed Data
As of 3:59pm ET
 +0.54 / +1.24%
Today’s Change
23.28
Today|||52-Week Range
63.73
+60.23%
Year-to-Date

Today’s Trading

Previous close43.41
Today’s open42.63
Day’s range42.25 - 44.24
Volume6,674,510
Average volume (3 months)2,081,507
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+79.02%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book7.06

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+2.14+10.16%
PRTAProthena Corporation...0.000.00%
IRWDIronwood Pharmaceuti...-0.11-0.64%
LGNDLigand Pharmaceutica...+0.69+0.56%
Data as of 4:02pm ET, 07/24/2017

Financials

Last reporting dateJuly 19, 2017
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts